Spots Global Cancer Trial Database for cea
Every month we try and update this database with for cea cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Dynamic Multi-omics Integration Model to Predict Neoadjuvant Therapy Response in Locally Advanced Rectal Cancer | NCT06364371 | Predictive Canc... Pathologic Comp... | Medical examina... | 18 Years - 80 Years | Sixth Affiliated Hospital, Sun Yat-sen University | |
| Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors | NCT06010862 | Gastric Cancer Colon Cancer Pancreas Cancer Esophagus Cance... Cholangiocarcin... Lung Cancer Breast Cancer | CEA CAR-T cells CEA CAR-T cells | 18 Years - | Chongqing Precision Biotech Co., Ltd | |
| Immunotherapy With CEA(6D) VRP Vaccine (AVX701) in Patients With Stage III Colorectal Cancer | NCT01890213 | Stage III Colon... | AVX701 | 18 Years - | Duke University | |
| A Clinical Research of CAR T Cells Targeting CEA Positive Cancer | NCT02349724 | Lung Cancer Colorectal Canc... Gastric Cancer Breast Cancer Pancreatic Canc... | Anti-CEA-CAR T | 18 Years - 80 Years | Southwest Hospital, China | |
| Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced Malignant Solid Tumors | NCT05415475 | Colorectal Canc... Esophageal Canc... Stomach Cancer Pancreatic Canc... Metastatic Tumo... Recurrent Cance... | CEA CAR-T cells | 18 Years - | Chongqing Precision Biotech Co., Ltd | |
| A Phase I/II Study With CEA(6D) VRP Vaccine in Patients With Advanced or Metastatic CEA-Expressing Malignancies | NCT00529984 | Colorectal Canc... Breast Cancer Lung Cancer Pancreatic Canc... Colon Cancer | AVX701 AVX701 AVX701 AVX701 AVX701 | 18 Years - | AlphaVax, Inc. | |
| Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced Malignant Solid Tumors | NCT05415475 | Colorectal Canc... Esophageal Canc... Stomach Cancer Pancreatic Canc... Metastatic Tumo... Recurrent Cance... | CEA CAR-T cells | 18 Years - | Chongqing Precision Biotech Co., Ltd | |
| The Effects of Chiropractic in Adults With Colon Cancer | NCT05310565 | Colon Cancer St... Colon Cancer St... | HVLA cervical c... | 18 Years - | Life University | |
| Feasibility, Reliability, and Satisfaction of CEA Using Home Based (Automated) Capillary Blood Sampling | NCT05646030 | Colorectal Canc... | TAP-II Lancet capillar... Venipuncture | 21 Years - | Erasmus Medical Center | |
| Immunotherapy for Colorectal Cancers Using CEA-Pulsed Dendritic Cells and Subsequent IL-2 Treatment | NCT00154713 | Colorectal Canc... | CEA pulsed dend... | 20 Years - 75 Years | National Taiwan University Hospital | |
| An Exploratory Clinical Study Evaluating the Safety and Efficacy of Anti-CEA-CAR-T Cells Injection in Patients With CEA+ Locally Advanced and/or Metastatic Solid Tumors | NCT06013111 | Carcinoma | Intravenous inf... | 18 Years - 70 Years | China Medical University, China | |
| PANVAC-V and PANVAC-F Vaccines Plus Sargramostim to Treat Advanced Cancer | NCT00088413 | Adenocarcinoma Colorectal Canc... Ovarian Cancer Breast Cancer | PANVAC-V PANVAC-F Sargramostim (G... | 18 Years - 100 Years | National Institutes of Health Clinical Center (CC) | |
| Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced Malignant Solid Tumors | NCT05415475 | Colorectal Canc... Esophageal Canc... Stomach Cancer Pancreatic Canc... Metastatic Tumo... Recurrent Cance... | CEA CAR-T cells | 18 Years - | Chongqing Precision Biotech Co., Ltd | |
| Immunotherapy With CEA(6D) VRP Vaccine (AVX701) in Patients With Stage III Colorectal Cancer | NCT01890213 | Stage III Colon... | AVX701 | 18 Years - | Duke University | |
| Phase 1b Study of CAR2Anti-CEA CAR-T Cell Hepatic Infusions for Pancreatic Carcinoma Patients With CEA+ Liver Metastases | NCT03818165 | Metastatic Panc... | CAR2 Anti-CEA C... | 18 Years - | Sorrento Therapeutics, Inc. | |
| Targeted T-cell Therapy in Solid Tumors | NCT04076137 | Malignant Solid... | Targeted T-cell... | 18 Years - 75 Years | Benhealth Biopharmaceutical (Shenzhen) Co., Ltd. | |
| Molecular Analysis in Peritoneal Washing Citology for Locally Advanced Gastric Cancer | NCT03098758 | Gastric Cancer Polymerase Chai... | 18 Years - | Corporacion Parc Tauli | ||
| An Exploratory Clinical Study Evaluating the Safety and Efficacy of Anti-CEA-CAR-T Cells Injection in Patients With CEA+ Locally Advanced and/or Metastatic Solid Tumors | NCT06013111 | Carcinoma | Intravenous inf... | 18 Years - 70 Years | China Medical University, China | |
| Evaluate the Safety and Efficacy of CAR-T in the Treatment of Pancreatic Cancer. | NCT03267173 | Pancreatic Canc... CAR | Chimeric antige... | 18 Years - 65 Years | First Affiliated Hospital of Harbin Medical University | |
| QUILT-3.040: ETBX-011 (Ad5 [E1-, E2b-]-CEA(6D)) Vaccine in Combination With ALT-803 (Super-agonist IL-15) in Subjects Having CEA-Expressing Cancer | NCT03127098 | Thyroid Cancer Colon Cancer Ovarian Cancer Breast Cancer Lung Cancer Pancreatic Canc... | ETBX-011 ALT-803 | 21 Years - | NantCell, Inc. | |
| Immunotherapy for Colorectal Cancers Using CEA-Pulsed Dendritic Cells and Subsequent IL-2 Treatment | NCT00154713 | Colorectal Canc... | CEA pulsed dend... | 20 Years - 75 Years | National Taiwan University Hospital | |
| Quantitative Detection of CEA mRNA in the Smog and Tissue Exudate Whole Process Collected During Laparoscopic (Robotic) Radical Gastrectomy in Gastric Cancer Patients | NCT06076265 | Gastric Cancer | Radical Gastric... | 18 Years - 80 Years | The Affiliated Hospital of Qingdao University | |
| Dynamic Multi-omics Integration Model to Predict Neoadjuvant Therapy Response in Locally Advanced Rectal Cancer | NCT06364371 | Predictive Canc... Pathologic Comp... | Medical examina... | 18 Years - 80 Years | Sixth Affiliated Hospital, Sun Yat-sen University | |
| A Clinical Study of CEA-targeted CAR-T in the Treatment of CEA-positive Advanced Malignant Solid Tumors | NCT05396300 | Colorectal Canc... Esophageal Canc... Stomach Cancer Pancreatic Canc... Metastatic Tumo... Recurrent Cance... | CEA CAR-T cells | 18 Years - | Zhejiang University | |
| Docetaxel Alone or in Combination With Vaccine to Treat Breast Cancer | NCT00179309 | Breast Cancer | Docetaxel PANVAC-V PANVAC-F Sargramostim | 18 Years - 85 Years | National Institutes of Health Clinical Center (CC) | |
| Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors | NCT06010862 | Gastric Cancer Colon Cancer Pancreas Cancer Esophagus Cance... Cholangiocarcin... Lung Cancer Breast Cancer | CEA CAR-T cells CEA CAR-T cells | 18 Years - | Chongqing Precision Biotech Co., Ltd | |
| Active Immunotherapy CEA Vaccine in Patients With Malignancies Expressing CEA | NCT01147965 | Colon Cancer Lung Cancer Breast Cancer | AD5 CEA Vaccine | 21 Years - 75 Years | Etubics Corporation |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
